Figure 1.
Figure 1. Summary of the patient's clinical history from admission to discharge. (A) Changes in body temperature and serum C reactive protein. (B) Changes in the serum IL-6 and IL-10 levels. (C) Changes in the human herpesvirus-8 viral load evaluated in peripheral blood mononuclear cells by quantitative PCR assay (log scale). Reduction of the immunosuppressive regimen are indicated at the bottom of the figure. Rituximab infusions (375 g/m2) are indicated by arrows. FK506 indicates tacrolimus; SRL, sirolimus; and MMF, mycophenolate mofetil.

Summary of the patient's clinical history from admission to discharge. (A) Changes in body temperature and serum C reactive protein. (B) Changes in the serum IL-6 and IL-10 levels. (C) Changes in the human herpesvirus-8 viral load evaluated in peripheral blood mononuclear cells by quantitative PCR assay (log scale). Reduction of the immunosuppressive regimen are indicated at the bottom of the figure. Rituximab infusions (375 g/m2) are indicated by arrows. FK506 indicates tacrolimus; SRL, sirolimus; and MMF, mycophenolate mofetil.

Close Modal

or Create an Account

Close Modal
Close Modal